Mucosal antibody response and SARS‐CoV‐2 shedding in patients with COVID‐19 related olfactory dysfunction

Documenti analoghi

• Molecular Characterization of Parvovirus B19 in Pregnant Women During the 2024 Outbreak in Belgium
  di: Florence Lemaitre, et al.
  Pubblicazione: (2025)
• Clinical efficacy of SARS‐CoV‐2 Omicron ‐neutralizing antibodies in immunoglobulin preparations for the treatment of agammaglobulinemia in patients with primary antibody deficiency
  di: Michael Karbiener, et al.
  Pubblicazione: (2024)
• Malaria and other infections induce polyreactive antibodies that impact SARS‐CoV‐2 seropositivity estimations in endemic settings
  di: Ruth Aguilar, et al.
  Pubblicazione: (2024)
• Oral Ad5 Vector‐Based SARS‐CoV‐2 Vaccine Effectively Induces Mucosal and Systemic Immune Responses in BALB/c Mice
  di: Tongyao Mao, et al.
  Pubblicazione: (2025)
• SARS‐CoV‐2 reinfection broadens the antibody responses and promotes the phenotypic differentiation of virus‐specific memory T cells in adolescents
  di: Xin‐Jing Zhao, et al.
  Pubblicazione: (2024)